Clinical Trial Update: Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Mayo Clinic comparing telehealth and in-person assessments in glioma patients undergoing oral chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Idh-mutant
• Glioblastoma
• Glioma
• Oligodendroglioma Idh-mutant and 1p 19q-codeleted

Snippet

Sponsor: Mayo Clinic | Conditions: Astrocytoma, IDH-Mutant, Glioblastoma | Phase 4 | Status: COMPLETED